BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27404046)

  • 21. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo.
    Knapp S; Florquin S; Golenbock DT; van der Poll T
    J Immunol; 2006 Mar; 176(5):3189-95. PubMed ID: 16493079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic expression of lipopolysaccharide-binding protein (Lbp) is induced by the gut microbiota through Myd88 and impairs glucose tolerance in mice independent of obesity.
    Molinaro A; Koh A; Wu H; Schoeler M; Faggi MI; Carreras A; Hallén A; Bäckhed F; Caesar R
    Mol Metab; 2020 Jul; 37():100997. PubMed ID: 32305515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing diet.
    de Oliveira MC; Menezes-Garcia Z; Arifa RD; de Paula TP; Andrade JM; Santos SH; de Menezes GB; de Souza Dda G; Teixeira MM; Ferreira AV
    J Nutr Biochem; 2015 Sep; 26(9):978-85. PubMed ID: 26013469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
    Nozaki Y; Fujita K; Wada K; Yoneda M; Kessoku T; Shinohara Y; Imajo K; Ogawa Y; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
    BMC Gastroenterol; 2015 Apr; 15():42. PubMed ID: 25881230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
    Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
    Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.
    Bruce KD; Szczepankiewicz D; Sihota KK; Ravindraanandan M; Thomas H; Lillycrop KA; Burdge GC; Hanson MA; Byrne CD; Cagampang FR
    Biochim Biophys Acta; 2016 Jul; 1861(7):584-93. PubMed ID: 27040510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function.
    Engstler AJ; Sellmann C; Jin CJ; Brandt A; Herz K; Priebs J; Bergheim I
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 28067024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of liver steatosis in germ-free mice following hypercaloric diets.
    Kaden-Volynets V; Basic M; Neumann U; Pretz D; Rings A; Bleich A; Bischoff SC
    Eur J Nutr; 2019 Aug; 58(5):1933-1945. PubMed ID: 29926176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4.
    Su GL; Klein RD; Aminlari A; Zhang HY; Steinstraesser L; Alarcon WH; Remick DG; Wang SC
    Hepatology; 2000 Apr; 31(4):932-6. PubMed ID: 10733550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes.
    Thirunavukkarasu C; Uemura T; Wang LF; Watkins SC; Gandhi CR
    J Cell Physiol; 2005 Aug; 204(2):654-65. PubMed ID: 15828022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
    Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
    Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An iso-α-acid-rich extract from hops (Humulus lupulus) attenuates acute alcohol-induced liver steatosis in mice.
    Hege M; Jung F; Sellmann C; Jin C; Ziegenhardt D; Hellerbrand C; Bergheim I
    Nutrition; 2018 Jan; 45():68-75. PubMed ID: 29129239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.
    Hamann L; Alexander C; Stamme C; Zähringer U; Schumann RR
    Infect Immun; 2005 Jan; 73(1):193-200. PubMed ID: 15618154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.
    Kanuri G; Landmann M; Priebs J; Spruss A; Löscher M; Ziegenhardt D; Röhl C; Degen C; Bergheim I
    Eur J Nutr; 2016 Apr; 55(3):1153-64. PubMed ID: 26003186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses.
    Dunzendorfer S; Lee HK; Soldau K; Tobias PS
    FASEB J; 2004 Jul; 18(10):1117-9. PubMed ID: 15132988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
    Jiang W; Liu J; Dai Y; Zhou N; Ji C; Li X
    J Gastroenterol Hepatol; 2015 May; 30(5):933-43. PubMed ID: 25559563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.